Steven Zanganeh
Overview
Explore the profile of Steven Zanganeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakhshi P, Ho J, Zanganeh S
Front Med Technol
. 2024 Feb;
6:1320690.
PMID: 38362126
Sex hormones play a pivotal role in modulating various physiological processes, with emerging evidence underscoring their influence on cancer progression and treatment outcomes. This review delves into the intricate relationship...
2.
Tavakol M, Hajipour M, Ferdousi M, Zanganeh S, Maurizi L
Nanoscale
. 2023 Oct;
15(43):17342-17349.
PMID: 37860936
The biological behavior and fate of nanoparticles are dependent on their retention time in the blood circulation system. The protein corona components, especially opsonins, and dysopsonins, adsorbed on the nanoparticle...
3.
Raoufi E, Hosseini F, Onagh B, Salehi-Shadkami M, Mehrali M, Mohsenzadegan M, et al.
Clin Chim Acta
. 2023 Mar;
542:117279.
PMID: 36871661
Background: More than 3 y into the coronavirus 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to undergo mutations. In this context, the Receptor Binding Domain (RBD)...
4.
Shekarian T, Zinner C, Bartoszek E, Duchemin W, Wachnowicz A, Hogan S, et al.
Sci Adv
. 2022 Jul;
8(26):eabn9440.
PMID: 35776791
A patient-tailored, ex vivo drug response platform for glioblastoma (GBM) would facilitate therapy planning, provide insights into treatment-induced mechanisms in the immune tumor microenvironment (iTME), and enable the discovery of...
5.
Bigdelou B, Sepand M, NajafiKhoshnoo S, Tavares Negrete J, Sharaf M, Ho J, et al.
Front Immunol
. 2022 Jun;
13:890517.
PMID: 35711466
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide, resulting in the declaration of a pandemic. When several countries...
6.
Sepand M, Bigdelou B, Ho J, Sharaf M, Lannigan A, Sullivan I, et al.
Antibodies (Basel)
. 2022 Jun;
11(2).
PMID: 35645208
Questions and concerns regarding the efficacy and immunogenicity of coronavirus disease 2019 (COVID-19) vaccines have plagued scientists since the BNT162b2 mRNA vaccine was introduced in late 2020. As a result,...
7.
Ho J, Sepand M, Bigdelou B, Shekarian T, Esfandyarpour R, Chauhan P, et al.
Immunology
. 2022 Apr;
166(4):429-443.
PMID: 35470422
The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and has a complex interaction with the immune system, including...
8.
Atashgah R, Ghasemi A, Raoufi M, Abdollahifar M, Zanganeh S, Nejadnik H, et al.
Mol Pharm
. 2021 Jul;
18(8):3171-3180.
PMID: 34279974
Current treatment of chronic wounds has been critically limited by various factors, including bacterial infection, biofilm formation, impaired angiogenesis, and prolonged inflammation. Addressing these challenges, we developed a multifunctional wound...
9.
Alvim R, Georgala P, Nogueira L, Somma A, Nagar K, Thomas J, et al.
Molecules
. 2021 Jul;
26(12).
PMID: 34205347
Purpose: Vascular targeted photodynamic therapy (VTP) is a nonsurgical tumor ablation approach used to treat early-stage prostate cancer and may also be effective for upper tract urothelial cancer (UTUC) based...
10.
Sepand M, Aghsami M, Keshvadi M, Bigdelou B, Behzad R, Zanganeh S, et al.
Environ Res
. 2021 Mar;
196:110933.
PMID: 33689818
Macrophages are a critical member of the innate immune system and can intensify tumor invasiveness and assist the growth of neoplastic cells. Moreover, they have the capability to reinforce immunosuppression...